Paraquat Contracts

Our Eligibility & Screening Criteria in Paraquat Cases

Your law firm needs a marketing team that has handled thousands of Paraquat cases to date on the front end and the administrative end. At Atraxia Media, we use your criteria for cases and understand what you're looking for. Then, following the goal of getting signed contracts to pay out in the end, we apply a marketing approach involving the following stages:

• Pre-screening. Clients find us when searching for information related to their legal issues. Our focus then is on following your criteria for cases, so that you can connect with the most promising prospects.
• Screening each case. During this phase, we're listening to your future clients, and we're engaging with their issues while also making sure their case is eligible based on your criteria.
• Following up on all our calls. If we decide the client is a good fit for your law firm, we follow up with them efficiently and check back on them frequently as a relationship-strengthening action.
• Getting you signed contracts based on your eligibility criteria. Atraxia Media's focus is to provide you with signed contracts.
• Delivering more clients to your law firm.
• Working to generate cases for you by using our own in-house marketing team, which has extensive expertise. We ensure that no potential plaintiffs are overlooked.
• Delivering paraquat potential plaintiffs entirely exclusive to your law firm.

Agricultural workers and others may be eligible to file a Paraquat lawsuit if they have been:

• Exposed to the herbicide Paraquat
• Diagnosed with Parkinson's disease

At Atraxia Media, we know it's important to start your client relationships off on the right foot. To start working exclusively for you, our internal team needs to know the number of cases you require. As a result, our marketing process is straightforward for your potential clients, efficient, and customized as per your needs.

Paraquat Facts & History

Paraquat lawsuits have grown to more than 6,000 after consolidation into multidistrict litigation in 2021. As more people learn that their diagnosis could be related to paraquat exposure, the number is only expected to increase.

Aside from cases filed directly into the MDL, Parkinson's patients exposed to paraquat products like Gramoxone have filed similar cases in state courts, like:

• California
• Illinois
• Wisconsin
• Arkansas
• Maryland
• Missouri
• Pennsylvania
• West Virginia

Plaintiffs who allege they've been diagnosed with Parkinson's disease after being exposed to paraquat-based herbicides have successfully petitioned the consolidation of paraquat cases into Multidistrict Litigation No. 3004 (Potential Paraquat Products Liability Litigation) in 2021.

Multidistrict litigation (MDL) is a formality that groups the paraquat cases to reduce overlap and expedite the legal process. As a result, there is no time to waste on a neurological disorder like Parkinson's. In addition, multidistrict litigation's efficiencies reduce redundancy and provide individuals with the quickest path to justice.

PARAQUAT PRODUCTS LIABILITY LITIGATION, MDL NO. 3004

Location:

• Southern District of Illinois

Presiding Judge:

• Chief Judge Nancy J. Rosenstengel

Plaintiffs:

• Plaintiffs include people who were exposed to paraquat and diagnosed with Parkinson's disease after exposure, including farmers and agricultural workers.

Defendants:

• Syngenta (Gramoxone manufacturer)
• Chevron Phillips Chemical Co. (CPChem)

Products:

Paraquat products like Gramoxone

Plaintiff Allegations:

Plaintiffs allege that paraquat products contribute to the development of Parkinson's disease after exposure. People who have handled herbicides allege that the manufacturer is liable for defective design and failure to warn consumers about the neurological risks that may result from regularly handling weed and grass killers.

History:

2025:

• October (scheduled): The first bellwether trial is scheduled on October 14, 2025. The second trial will take place in 2026.
• June: Plaintiffs and defendants are expected to give an update on a potential settlement agreement by June 11, 2025.
• May: There were 6,036 pending MDL dockets in the Paraquat Products Liability Litigation by May 1, 2025.
• April: According to a court filing, Sygenta has entered into a settlement agreement with the plaintiffs' lead counsel. The Letter Agreement aims to settle thousands of paraquat lawsuits.

2024:

• December: Out of the ten cases selected for potential bellwether trials in MDL 3004, six cases had already completed the limited case-specific discovery phase. On the other hand, paraquat cases filed in state courts encountered delays. Judge Charles Treat, who presides over Paraquat cases filed in California state courts, excluded Dr. Martin Wells from giving expert testimony. Dr. Wells was also barred from giving expert testimony in the MDL by Judge Rosenstengel, leading to the dismissal of the initial bellwether cases.
• October: According to an order issued by Judge Rosenstengel, two individual lawsuits were selected to be part of 10 cases that would move forward to the discovery phase, after two plaintiffs backed out as potential bellwether cases.
• September: A Colorado resident filed a lawsuit against Sygenta AG and Syngenta Crop Protection, LLC, alleging that his Parkinson's disease was caused by long-term paraquat exposure from the company's products.
• April: Four cases potentially selected for bellwether trials were dismissed by summary judgment after the judge barred expert testimony from the plaintiffs' expert, Dr. Martin Wells.

2022:

• June: The court postponed the first paraquat bellwether trial scheduled on November 15, 2022, due to the increasing number of paraquat cases.

2021:

• June: The US Judicial Panel on Multidistrict Litigation created MDL No. 3004, or the Paraquat Products Liability Litigation, in the Southern District of Illinois. The MDL was presided over by Chief Judge Nancy J. Rosenstengel.